Oppenheimer Asset Management Inc. Buys 2,611 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Oppenheimer Asset Management Inc. boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 16.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,895 shares of the company’s stock after purchasing an additional 2,611 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Acadia Healthcare were worth $1,198,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACHC. Russell Investments Group Ltd. boosted its position in Acadia Healthcare by 9.7% during the first quarter. Russell Investments Group Ltd. now owns 9,876 shares of the company’s stock worth $782,000 after purchasing an additional 875 shares during the period. State Board of Administration of Florida Retirement System boosted its position in shares of Acadia Healthcare by 3.8% in the first quarter. State Board of Administration of Florida Retirement System now owns 88,459 shares of the company’s stock valued at $6,391,000 after acquiring an additional 3,263 shares during the period. Clearbridge Investments LLC boosted its position in shares of Acadia Healthcare by 2.3% in the first quarter. Clearbridge Investments LLC now owns 202,550 shares of the company’s stock valued at $16,046,000 after acquiring an additional 4,492 shares during the period. CANADA LIFE ASSURANCE Co boosted its position in shares of Acadia Healthcare by 14.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 58,505 shares of the company’s stock valued at $4,637,000 after acquiring an additional 7,491 shares during the period. Finally, MQS Management LLC bought a new stake in shares of Acadia Healthcare in the first quarter valued at about $322,000.

Acadia Healthcare Stock Down 1.8 %

Shares of NASDAQ ACHC opened at $37.13 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $3.45 billion, a price-to-earnings ratio of 12.17, a PEG ratio of 1.68 and a beta of 1.33. Acadia Healthcare Company, Inc. has a 12 month low of $36.50 and a 12 month high of $87.77. The stock has a 50-day moving average price of $57.27 and a two-hundred day moving average price of $65.34.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 earnings per share. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of recent research reports. Barclays reduced their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday. KeyCorp started coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $83.33.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.